文献速递泌尿男性生殖肿瘤

家族性与遗传性癌症综合征相关的前列腺癌风险

Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.
PubMed 文献 · J Clin Oncol · 2020-03-24

基于犹他州人群数据库619630名≥40岁男性,评估遗传性前列腺癌、遗传性乳腺癌卵巢癌综合征和Lynch综合征家族史与前列腺癌风险的关系。结果显示遗传性前列腺癌家族史风险最高(RR 2.30,95%CI 2.22-2.40),所有综合征家族史与早发型疾病风险关联最强。

要点

  • 遗传性前列腺癌家族史者前列腺癌风险最高,RR为2.30。
  • HBOC和Lynch综合征家族史也显著增加前列腺癌风险。
  • 所有综合征家族史与早发型前列腺癌风险关联最强。

核心结论

  • 前列腺癌风险因癌症家族史而异,与早发型疾病关联最强。

研究设计与样本

  • 基于犹他州人群数据库的队列研究,纳入619630名≥40岁、属于至少连续3代家系的男性。

主要发现

  • 遗传性前列腺癌家族史与所有亚型合并的前列腺癌相对风险最高,RR为2.30(95%CI 2.22-2.40)。
  • HBOC和Lynch综合征家族史也显示统计学显著的风险增加(1<RR<2)。
  • 所有家系类型中,家族史与早发型疾病的风险关联最强。

临床怎么用

  • 结果有助于识别可从遗传筛查和加强监测中获益的高风险人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recently developed clinical guidelines suggest that men in families with specific cancer syndromes, such as hereditary breast and ovarian cancer (HBOC), consider genetic testing, especially in the setting of aggressive disease. However, although a family history (FH) of the same disease among close relatives is an established risk factor for prostate cancer (PC), a direct comparison of PC risk for men with each syndrome in a single population is needed. METHODS: The Utah Population Database was used to identify 619,630 men, age ≥ 40 years, who were members of a pedigree that included at least 3 consecutive generations. Each man was evaluated for FH of hereditary PC (HPC), HBOC, and Lynch syndrome (LS) and for his own PC status. PC occurrences (N = 36,360) were classified into one or more subtypes: early onset (EO), lethal, and/or clinically significant. Relative risks (RRs) associated with each subtype, adjusted for important covariables, were calculated in STATA using a modified Poisson regression with robust error variances to obtain corresponding RR CIs for each FH definition. RESULTS: An FH of HPC conveyed the greatest relative risk for all PC subtypes combined (RR, 2.30; 95% CI, 2.22 to 2.40), followed by HBOC and LS (both with 1 < RR < 2 and statistically significant). The strongest risks associated with FH were observed for EO disease in all pedigree types, consistent with the contribution of genetic factors to disease occurrence. CONCLUSION: In this large, population-based, family database, the risk of PC varied by cancer FH and was most strongly associated with EO disease. These results are critically valuable in understanding and targeting high-risk populations that would benefit from genetic screening and enhanced surveillance.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Beebe-Dimmer JL, Kapron AL, Fraser AM, et al. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes. J Clin Oncol. 2020. PMID: 32208047. doi:10.1200/JCO.19.02808

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。